Miriam Fuhrman, MD
Ophthalmology · Paterson, NJNPI 1780807206
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 259 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,912, 3.4 times the $849 reported in 2019. Among ophthalmology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 259 payments — averaging $50.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Glaukos Corporation$2K
- Alcon$1K
- Sight Sciences, Inc.$1K
- Bausch & Lomb Americas Inc.$1K
- Johnson & Johnson Surgical Vision, Inc.$750
- plus $5K from 22 others
What the payments were for
- Food & beverage$13,04499%
- Education$981%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 70 | $2,234 |
| Glaukos Corporation | 11 | $1,548 |
| Alcon | 25 | $1,257 |
| Sight Sciences, Inc. | 10 | $1,253 |
| Bausch & Lomb Americas Inc. | 17 | $1,082 |
| Johnson & Johnson Surgical Vision, Inc. | 6 | $750 |
| Amgen(2 entities) | 23 | $634 |
| Tarsus Pharmaceuticals, Inc. | 14 | $535 |
| Biotissue Holdings Inc. | 6 | $408 |
| Aerie Pharmaceuticals, Inc. | 16 | $359 |
| Sun Pharmaceutical Industries Inc. | 3 | $346 |
| NEW World Medical,inc. | 2 | $336 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 13 | $295 |
| Astellas Pharma US Inc | 2 | $268 |
| Oyster Point Pharma, Inc. | 9 | $248 |
| Eyevance Pharmaceuticals LLC | 9 | $247 |
| Apellis Pharmaceuticals, Inc. | 2 | $235 |
| Harrow Eye, LLC | 7 | $196 |
| Dompe US, Inc. | 3 | $159 |
| Rxsight Inc | 1 | $139 |
| Mallinckrodt Hospital Products Inc. | 1 | $138 |
| Lumenis BE Inc | 1 | $134 |
| Rayner Intraocular Lenses Limited | 1 | $125 |
| Kala Pharmaceuticals, Inc. | 1 | $119 |
| Omeros Corporation | 1 | $30 |
| Shire North American Group Inc | 2 | $28 |
| Novartis | 2 | $25 |
| Ocular Therapeutix, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- enVista MX60 IOL$1,204
- OMNI(R) SURGICAL SYSTEM (US)$1,063
- DURYSTA$834
- Tecnis IOL$647
- SION SURGICAL INSTRUMENT$538
- Clareon$523
- XDEMVY$477
- iStent inject Trabecular Micro-Bypass Stent System$395
- CEQUA$346
- Kahook Dual Blade$304
- Streamline Surgical System$304
- Ahmed Glaucoma Valve$304
- iStent inject W$297
- KXL System$283
- Photrexa$283
- Izervay$268
- TEPEZZA$260
- CATALYS SYSTEM$258
- Tecnis Simplicity$249
- Prokera$239
How this compares
$13,142 in reported general payments places this provider in the 90th percentile of 583 ophthalmology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 351 | $347,903 |
| XiidraLifitegrast | 114 | $155,688 |
| LumiganBimatoprost | 248 | $120,208 |
| CombiganBrimonidine Tartrate/Timolol | 130 | $39,076 |
| RocklatanNetarsudil Mesylat/Latanoprost | 91 | $37,956 |
| Cyclosporine | 55 | $33,931 |
| XdemvyLotilaner | 15 | $28,095 |
| RhopressaNetarsudil Mesylate | 57 | $22,971 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 97 | $13,502 |
| Tobradex StTobramycin/Dexamethasone | 45 | $10,415 |
| VyzultaLatanoprostene Bunod | 26 | $7,951 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 24 | $6,186 |
| Alphagan PBrimonidine Tartrate | 18 | $6,175 |
| Brimonidine Tartrate | 79 | $5,465 |
| Latanoprost | 598 | $4,927 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Alphagan P | $2,234 | $513,362747 claims |
| Bausch & Lomb Americas Inc.Xiidra, Vyzulta | $1,082 | $163,639140 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan, Rhopressa | $359 | $60,927148 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $535 | $28,09515 claims |
| Eyevance Pharmaceuticals LLCTobradex St, Flarex | $247 | $14,42278 claims |
| AlconSimbrinza | $1,257 | $6,18624 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa | $295 | $4,47513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 583 ophthalmology providers in New Jersey.
Other ophthalmology in Paterson
- Jai ParekhWoodland Park$2M
- Sharad MansukaniMoorestown$744K
- Ravi PatelEatontown$729K
- Cynthia MatossianPennington$655K
- Eric MannDover$604K
- Brett BieloryRutherford$477K
- Albert KhouriNewark$428K
- Robert FechtnerNewark$324K
- Rajen DesaiFreehold$311K
- Douglas GraysonIselin$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.